Regulation of NAD+ metabolism in aging and disease
Author:
Funder
National Institutes of Health
U.S. Department of Defense
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference154 articles.
1. Clinical evidence for targeting NAD therapeutically;Radenkovic;Pharmaceuticals (Basel),2020
2. Therapeutic potential of NAD-boosting molecules: the in vivo evidence;Rajman;Cell Metab,2018
3. Sirtuin regulation in aging and injury;Poulose;Biochim Biophys Acta,2015
4. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+;Belenky;Cell.,2007
5. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling;Ray Chaudhuri;Nat Rev Mol Cell Biol,2017
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Does Microbiome Contribute to Longevity? Compositional and Functional Differences in Gut Microbiota in Chinese Long-Living (>90 Years) and Elderly (65–74 Years) Adults;OMICS: A Journal of Integrative Biology;2024-09-01
2. NAD+ metabolism and therapeutic strategies in cardiovascular diseases;Atherosclerosis Plus;2024-09
3. The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update;Cells;2024-09-01
4. Unfolding the complexity of epigenetics in male reproductive aging: a review of therapeutic implications;Molecular Biology Reports;2024-08-01
5. Long COVID as a disease of accelerated biological aging: An opportunity to translate geroscience interventions;Ageing Research Reviews;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3